The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic ...

The most common side effects of INVEGA HAFYERA® include: injection site reactions, weight gain, headache, upper respiratory ...

Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

Psychosis affects one's physical, psychological, social, and existential health. Mental health recovery often involves a ...

The scientists asked about 40 study participants—a mixture of neurotypical individuals and patients with schizophrenia—to ...

A larger, modern clubhouse replaced Club Nova’s nearly 100-year-old mill home that was packed with programs, members.

Researchers have identified a potential diagnostic tool for schizophrenia by measuring brain cell activity between the ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...

Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...